Boston Scientific Announces CE Mark Approval and First Use of Blazer Open-Irrigated Catheter in Europe

Boston Scientific Corporation BSX today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product is being launched this quarter in select CE Mark countries.